RBC Capital Reiterates Outperform Rating on Corbus Pharmaceuticals (CRBP)

Go back to RBC Capital Reiterates Outperform Rating on Corbus Pharmaceuticals (CRBP)

Form S-8 Corbus Pharmaceuticals

May 31, 2024 4:40 PM EDT

As filed with the Securities and Exchange Commission on May 31, 2024

Registration No. 333-

... More